ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 65 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 9.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $264,000 | +8.6% | 113,100 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $243,000 | -6.2% | 113,100 | 0.0% | 0.01% | -16.7% |
| Q4 2014 | $259,000 | -14.2% | 113,100 | 0.0% | 0.01% | -14.3% |
| Q3 2014 | $302,000 | -28.4% | 113,100 | 0.0% | 0.01% | -64.1% |
| Q2 2014 | $422,000 | -68.3% | 113,100 | 0.0% | 0.04% | -70.7% |
| Q1 2014 | $1,330,000 | +41.0% | 113,100 | 0.0% | 0.13% | +34.3% |
| Q4 2013 | $943,000 | -10.0% | 113,100 | 0.0% | 0.10% | -15.4% |
| Q3 2013 | $1,048,000 | -5.4% | 113,100 | 0.0% | 0.12% | -22.5% |
| Q2 2013 | $1,108,000 | – | 113,100 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Steamboat Capital Partners, LLC | 817,521 | $414,000 | 0.37% |
| Abingworth LLP | 396,104 | $195,000 | 0.19% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,638 | $31,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 128,520 | $65,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 949,438 | $481,000 | 0.00% |
| Renaissance Technologies | 908,100 | $460,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $23,000 | 0.00% |
| DEUTSCHE BANK AG\ | 5 | $0 | 0.00% |
| CITIGROUP INC | 10,376 | $5,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 20,037 | $10,000 | 0.00% |